BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25658809)

  • 1. Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex.
    O'Connor BP; Danhorn T; De Arras L; Flatley BR; Marcus RA; Farias-Hesson E; Leach SM; Alper S
    PLoS Genet; 2015 Feb; 11(2):e1004932. PubMed ID: 25658809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.
    De Arras L; Alper S
    PLoS Genet; 2013 Oct; 9(10):e1003855. PubMed ID: 24204290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Splicing Factor hnRNP M Is a Critical Regulator of Innate Immune Gene Expression in Macrophages.
    West KO; Scott HM; Torres-Odio S; West AP; Patrick KL; Watson RO
    Cell Rep; 2019 Nov; 29(6):1594-1609.e5. PubMed ID: 31693898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.
    Blumhagen RZ; Hedin BR; Malcolm KC; Burnham EL; Moss M; Abraham E; Huie TJ; Nick JA; Fingerlin TE; Alper S
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L930-L939. PubMed ID: 28775099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo.
    Tanackovic G; Krämer A
    Mol Biol Cell; 2005 Mar; 16(3):1366-77. PubMed ID: 15647371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transcriptional regulation of gene expression in innate immunity.
    Carpenter S; Ricci EP; Mercier BC; Moore MJ; Fitzgerald KA
    Nat Rev Immunol; 2014 Jun; 14(6):361-76. PubMed ID: 24854588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of the U2 snRNP-associated splicing factor SF3a.
    Krämer A; Ferfoglia F; Huang CJ; Mulhaupt F; Nesic D; Tanackovic G
    Biochem Soc Trans; 2005 Jun; 33(Pt 3):439-42. PubMed ID: 15916536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR activation pathways in HIV-1-exposed seronegative individuals.
    Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
    J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.
    De Arras L; Laws R; Leach SM; Pontis K; Freedman JH; Schwartz DA; Alper S
    Genetics; 2014 Jun; 197(2):485-96. PubMed ID: 24361939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.
    Säemann MD; Weichhart T; Zeyda M; Staffler G; Schunn M; Stuhlmeier KM; Sobanov Y; Stulnig TM; Akira S; von Gabain A; von Ahsen U; Hörl WH; Zlabinger GJ
    J Clin Invest; 2005 Feb; 115(2):468-75. PubMed ID: 15650774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis H37Rv infection regulates alternative splicing in Macrophages.
    Zhang W; Niu C; Fu RY; Peng ZY
    Bioengineered; 2018 Jan; 9(1):203-208. PubMed ID: 29433383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
    Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
    Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new role for myeloid HO-1 in the innate to adaptive crosstalk and immune homeostasis.
    Koliaraki V; Kollias G
    Adv Exp Med Biol; 2011; 780():101-11. PubMed ID: 21842368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.
    Lee FFY; Alper S
    Front Immunol; 2022; 13():1023567. PubMed ID: 36531997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor ARF regulates innate immune responses in mice.
    Través PG; López-Fontal R; Luque A; Hortelano S
    J Immunol; 2011 Dec; 187(12):6527-38. PubMed ID: 22095712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced photoreceptor death and improved retinal function during retinal degeneration in mice lacking innate immunity adaptor protein MyD88.
    Syeda S; Patel AK; Lee T; Hackam AS
    Exp Neurol; 2015 May; 267():1-12. PubMed ID: 25725353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
    Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
    J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.
    Li H; Hong F; Pan S; Lei L; Yan F
    Inflammation; 2016 Feb; 39(1):199-208. PubMed ID: 26277357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
    Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
    Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.